Previous studies reported that PD-L1 promotes EMT features and cancer cell stemness, and EMT enriches PD-L1 in CSCs by the EMT/β-catenin/STT3/PD-L1 signaling axis 6, 7. This evidence concerns the gene CD274 and cancer.